김승기 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

최종업데이트 2018.04.23.

Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression
- Exp. Mol. Med., 05 June 2026 | https://doi.org/10.1038/s12276-026-01732-0
- 2026-06
- 의약학
- 한빛사논문
Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas
- Acta Neuropathol., First Online: 11 April 2018 | https://doi.org/10.1007/s00401-018-1845-8
- 2018-04
- 의약학
- 한빛사논문
- 김승기(Harvard Medical School)
Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression
- Clin. Cancer Res., Published 15 September 2006 | DOI: 10.1158/1078-0432.CCR-05-2508
- 2006-09
- 의약학
- 상위피인용논문

연구자 ID

저자논문